AAAAAA

   
Results: 1-10 |
Results: 10
THE NEW SYNTHETIC FLAVONOID S-17834 INHIBITS LEUKOCYTE ADHESION IN-VITRO AND IN-VIVO
Authors: RUPIN K COKELAER P VALLEZ MO WIERZBICKI M BOUSKELA E VERBEUREN TJ
Citation: K. Rupin et al., THE NEW SYNTHETIC FLAVONOID S-17834 INHIBITS LEUKOCYTE ADHESION IN-VITRO AND IN-VIVO, Journal of vascular research, 35, 1998, pp. 130-130
THE NOVEL FLAVONOID, S-17834, INHIBITS PERMEABILITY IN THE HAMSTER-CHEEK POUCH
Authors: VALLEZ MO CYRINO FZGA BOUSKELA E BOUSSARD MF WIERZBICKI M VERBEUREN TJ
Citation: Mo. Vallez et al., THE NOVEL FLAVONOID, S-17834, INHIBITS PERMEABILITY IN THE HAMSTER-CHEEK POUCH, Journal of vascular research, 35, 1998, pp. 131-131
OFF-LINE ANALYSIS OF GLOMERULAR BLOOD-FLOW (GBF) IN THE HYDRONEPHROTIC RAT-KIDNEY
Authors: DEVRIESE A VALLEZ MO VERBEUREN TJ
Citation: A. Devriese et al., OFF-LINE ANALYSIS OF GLOMERULAR BLOOD-FLOW (GBF) IN THE HYDRONEPHROTIC RAT-KIDNEY, Journal of vascular research, 35, 1998, pp. 196-196
THE DIRECT THROMBIN INHIBITOR S-18326 HAS ADDITIONAL ACTIVITY ON TISSUE FACTOR FACTOR-VIIA AND HIGH EFFICACY ON VENOUS THROMBOSIS
Authors: RUPIN A VALLEZ MO MENNECIER P DENANTEUIL G VERBEUREN TJ
Citation: A. Rupin et al., THE DIRECT THROMBIN INHIBITOR S-18326 HAS ADDITIONAL ACTIVITY ON TISSUE FACTOR FACTOR-VIIA AND HIGH EFFICACY ON VENOUS THROMBOSIS, Thrombosis and haemostasis, 1997, pp. 384-384
EFFICIENCY OF THE DIRECT THROMBIN INHIBITOR S-18326 IN A NEW CANINE MODEL OF VENOUS THROMBOSIS
Authors: VERBEUREN TJ VALLEZ MO RUPIN A VERSLUYS D SIMONET S DENANTEUIL G
Citation: Tj. Verbeuren et al., EFFICIENCY OF THE DIRECT THROMBIN INHIBITOR S-18326 IN A NEW CANINE MODEL OF VENOUS THROMBOSIS, Thrombosis and haemostasis, 1997, pp. 387-387
THE NEW ORALLY-ACTIVE THROMBIN INHIBITOR S-18326 DOES NOT POSSESS INFLAMMATORY EFFECTS AT ANTITHROMBOTIC DOSES
Authors: RUPIN A VALLEZ MO MENNECIER P COURCHAY C DENANTEUIL G VERBEUREN TJ
Citation: A. Rupin et al., THE NEW ORALLY-ACTIVE THROMBIN INHIBITOR S-18326 DOES NOT POSSESS INFLAMMATORY EFFECTS AT ANTITHROMBOTIC DOSES, Thrombosis and haemostasis, 1997, pp. 2232-2232
ACTIVATION OF THROMBOXANE RECEPTORS AND THE INDUCTION OF VASOMOTION IN THE HAMSTER-CHEEK POUCH MICROCIRCULATION
Authors: VERBEUREN TJ VALLEZ MO LAVIELLE G BOUSKELA E
Citation: Tj. Verbeuren et al., ACTIVATION OF THROMBOXANE RECEPTORS AND THE INDUCTION OF VASOMOTION IN THE HAMSTER-CHEEK POUCH MICROCIRCULATION, British Journal of Pharmacology, 122(5), 1997, pp. 859-866
SELECTIVE POTENTIATION OF IN-VITRO RENAL CONSTRICTIONS TO ADRENERGIC ACTIVATION THROMBOXANE NEUROPEPTIDE-Y IN DIABETIC RATS
Authors: VERBEUREN TJ VALLEZ MO PETIT C MORANVILLIER I COHEN RA
Citation: Tj. Verbeuren et al., SELECTIVE POTENTIATION OF IN-VITRO RENAL CONSTRICTIONS TO ADRENERGIC ACTIVATION THROMBOXANE NEUROPEPTIDE-Y IN DIABETIC RATS, The FASEB journal, 10(3), 1996, pp. 868-868
ANTITHROMBOTIC PROPERTIES OF S 18326 - A NEW POTENT ORALLY-ACTIVE TRIPEPTIDIC BORONIC ACID THROMBIN INHIBITOR
Authors: VERBEUREN TJ RUPIN A SIMONET S VALLEZ MO DENANTEUIL G
Citation: Tj. Verbeuren et al., ANTITHROMBOTIC PROPERTIES OF S 18326 - A NEW POTENT ORALLY-ACTIVE TRIPEPTIDIC BORONIC ACID THROMBIN INHIBITOR, Thrombosis and haemostasis, 73(6), 1995, pp. 1310-1310
S-18204 - A NEW POWERFUL TXA(2)-RECEPTOR ANTAGONIST WITH A LONG-DURATION OF ACTION
Authors: VERBEUREN TJ SIMONET S DESCOMBES JJ VALLEZ MO LAUBIE M LAVIELLE G
Citation: Tj. Verbeuren et al., S-18204 - A NEW POWERFUL TXA(2)-RECEPTOR ANTAGONIST WITH A LONG-DURATION OF ACTION, Thrombosis and haemostasis, 73(6), 1995, pp. 1324-1324
Risultati: 1-10 |